-+ 0.00%
-+ 0.00%
-+ 0.00%

ProQR Therapeutics Q4 EPS $(0.09) Misses $(0.08) Estimate, Sales $5.458M Miss $8.550M Estimate

Benzinga·03/12/2026 22:17:07
Listen to the news
ProQR Therapeutics (NASDAQ:PRQR) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.08) by 12.5 percent. This is a 10 percent increase over losses of $(0.10) per share from the same period last year. The company reported quarterly sales of $5.458 million which missed the analyst consensus estimate of $8.550 million by 36.16 percent. This is a 18.73 percent increase over sales of $4.597 million the same period last year.